Balkrishna Industries Ltd. moves to reshape its capital structure

The Rs 550 Crores is not publicly earmarked for Bhuj, Waluj, or any other named capacity-expansion project. However, it is also not expressly described as being for “general corporate purposes.” The August 18, 2026 filing only approves the issue of up to 55,000 listed, senior, unsecured NCDs aggregating up to Rs 550 Crores through private placement; it does not specify an end-use of proceeds. ^[1]

The most accurate classification is therefore general funding flexibility / unallocated corporate financing, rather than project-tied capex funding. The filing also states that the issuance is within the company’s existing borrowing limits. ^[1]

This means:

• Bhuj or Waluj linkage: not disclosed or established in the issuance announcement.
• General corporate purpose: not expressly stated either.
• What is confirmed: approval to raise debt of up to Rs 550 Crores; the final tenure, coupon and redemption details were to be disclosed at allotment. ^[2]
• Important nuance: “up to Rs 550 Crores” is the approved issue size, not necessarily the amount already raised or deployed.

Accordingly, the proceeds could ultimately support the broader capex programme, refinance existing borrowings, or fund other corporate requirements, but assigning them specifically to Bhuj or Waluj would be an inference rather than a disclosed use.

Assuming the Rs 550 Crores NCD is incremental debt and the proceeds are not used to repay existing borrowings, gross debt-to-equity would rise from approximately 0.37x to 0.43x. Net debt-to-equity would remain around 0.37x if the proceeds are retained as cash, but would also move to roughly 0.42x once deployed. Interest coverage would decline because of the additional interest burden, although the reported coverage remains high; an exact pro forma ratio requires the company’s existing interest expense and the final NCD coupon.

Debt-ratio impact

At Q4 FY26, consolidated total debt was Rs 4,105.6 Crores, net debt was Rs 4,044.6 Crores and total equity was Rs 10,955.3 Crores. The reported gross debt-to-equity ratio was 0.37x and net debt-to-equity was also 0.37x. ^{[3] [4] [5] [6] [7]}

The issuance has been reported as a Rs 550 Crores NCD issue. ^[8] The balance-sheet effect therefore depends primarily on whether the funds are held temporarily as cash, used for capex or working capital, or applied toward refinancing existing debt.

Interest-coverage impact

Q4 FY26 consolidated interest coverage was 17.55x, while TTM interest coverage was 13.30x. ^{[9] [10]} The TTM figure is the more conservative reference because it smooths quarterly volatility.

A retrieved NCD issuance listing indicates a 7.53% coupon. If that coupon applies to the full Rs 550 Crores issuance, the incremental annual interest would be approximately Rs 41.4 Crores, calculated as Rs 550 Crores × 7.53%; the quarterly equivalent is approximately Rs 10.4 Crores. ^[11]

The revised coverage would be:

• Quarterly: new interest coverage = existing EBIT / existing interest plus Rs 10.4 Crores.
• TTM: new interest coverage = existing TTM EBIT / existing TTM interest plus Rs 41.4 Crores.

Because existing EBIT and interest expense are not separately reported in the supplied quarterly KPI set, the revised coverage cannot be calculated precisely. Mechanically, it will be below the reported 17.55x quarterly and 13.30x TTM levels, with the magnitude depending on the current interest base and whether the NCD replaces or adds to existing borrowing.

Implication: the issuance is a moderate increase in balance-sheet leverage rather than a step-change: gross debt-to-equity would move toward 0.43x, and coverage would weaken by the incremental coupon cost. The effect is materially smaller if the NCD refinances existing debt or if the proceeds generate additional EBIT before the full interest burden is incurred.

Verdict: The Rs 550 Cr NCD approval is evidence of an evolving capital-allocation approach, but not yet proof of a formal policy change. BKT has already moved from a cash-plus-investments position toward net debt during its elevated capex cycle; the proposed issuance would make debt a more explicit marginal source of growth funding. However, the filing approves an issuance up to Rs 550 Cr and does not specify whether the proceeds will fund OHT, on-highway expansion, general capex, or refinancing. The debentures may also be issued in tranches, so the approval is not equivalent to Rs 550 Cr of incremental debt outstanding. ^[1]

Balance-sheet inflection

The change is visible before the latest NCD approval:

• On a cash-plus-investments basis, BKT had approximately Rs 82 Cr of net cash at Q4 FY25, derived from Rs 3,262.6 Cr of total debt ^[3], Rs 80.2 Cr of cash ^[12], and Rs 3,264.3 Cr of investments ^[13].
• The same mechanical calculation at Q4 FY26 produces approximately Rs 921 Cr of net debt, based on Rs 4,105.6 Cr of total debt ^[3], Rs 60.9 Cr of cash ^[12], and Rs 3,124.0 Cr of investments ^[13]. This is a cash-plus-investments calculation, not the company-reported cash-only net-debt measure.
• The consolidated debt-to-equity ratio increased from 0.31x in Q4 FY25 to 0.37x in Q4 FY26, while reported net debt rose to Rs 4,044.6 Cr on the cash-only measure. ^{[6] [7]}
• Q1 FY27 analyst commentary reported gross debt of approximately Rs 4,690 Cr, cash balances of approximately Rs 2,965 Cr and net debt of roughly Rs 1,725 Cr, indicating that leverage continued to build as the capex programme progressed. ^[14]

The issuance is within the company’s existing borrowing limits under Section 180(1)(c) of the Companies Act. It consists of rated, listed, senior, unsecured, redeemable, non-cumulative NCDs placed privately with eligible investors; coupon, maturity and redemption terms were to be disclosed at allotment. ^{[1] [2]}

Comparison with the historical OHT funding model

Historically, BKT was characterised as a cash-generative, low-debt compounder, with expansion largely supported by internal cash generation and retained balance-sheet liquidity rather than sustained structural leverage. ^[15] The cash-flow pattern is consistent with that description:

• In the TTM period ending FY25, investing cash flow was an outflow of Rs 1,479.4 Cr and financing cash flow was an outflow of Rs 279.0 Cr. ^{[16] [17]}
• By the TTM period ending FY26, investing cash flow had widened to an outflow of Rs 2,523.0 Cr, while financing cash flow turned positive at Rs 254.2 Cr. ^{[16] [17]}
• TTM operating cash flow was Rs 2,249.3 Cr in FY26, broadly funding a substantial portion of the increased investment outlay, although investing cash flow is broader than capex alone. ^{[18] [16]}

The distinction is therefore one of degree and timing, not a complete reversal:

• Historical OHT expansion: predominantly internally funded, with low leverage and a preference to preserve financial flexibility.
• Current expansion cycle: front-loaded investment has pushed the company into net debt, with debt now being used alongside operating cash flow and investments.
• Latest NCD approval: formalises debt as an available funding tool, but remains incremental rather than transformational because leverage is still moderate and the issue is within existing borrowing limits.

The current capex cycle is also broader than historical OHT capacity expansion. Management’s programme covers approximately Rs 6,800 Cr through FY29, with around Rs 3,800 Cr reportedly spent and approximately Rs 3,000 Cr still to be deployed; the strategic agenda includes on-highway tyres, backward integration and consumer-segment development. ^{[14] [19]}

Analytical conclusion: This is best viewed as a transition from a self-funded, net-cash expansion model to a balanced funding model in which debt helps bridge a temporary capex peak. It would represent a more meaningful policy shift only if BKT continues issuing debt after the current investment cycle, allows net leverage to remain elevated, or explicitly adopts a target leverage framework. Project-level funding for the historical OHT build and the precise use of proceeds from this NCD issue are not separately reported.